Member Info for Okehurst1

Sadly the U.K. won’t dodge this new variant, just a question of when not if

https://www.usatoday.com/story/news/health/2021/12/08/omicron-covid-variant-vaccines-mandates/6425346001/

It’s encouraging that the EU this week recognises that the Mologic biotech identifies all previous strains on Covid 19, Tbf their reagent is up there as one of the best in the world - by default this of course is in our LFT

Think we can have confidence that Mologic / Gates will in time advise they have this new variant covered - it’s all about the N protein and the Mologic biotech targets same.

We just need EU HUA and we rerate

Let’s hope so Regulator

Ditto EU HUA within next week or so - next list update

Nb the market has picked up on that fact hence the near 25% jump in the share price

TW, agree

Thinking ….the EU have cleared the biotech of the Omega test - by default we would have used the FIND data

We submitted under EU HUA alongside submitting the Ulster Trial results, which Omega called ‘ the last piece of the Jigsaw’

In effect it’s all down to the engineering element now not the biotech

That’s my view on the current situation

TW, very

Can’t see the buffer/ reagent and even the film being any different that Omega submitted

Omega handled the ‘ ease of use ‘ trial - as we know - which was all about the engineering of the LFT.

It’s good news today that the biotech has cleared, guess it’s all about the EU body satisfied with the Ulster data

Suggest this is our position tonight?

Suggest on the back of ‘ our’ biotech clearing EU

We are now down to ‘ ease of use ‘

Final hurdle

Marcus, thanks for sharing.

One hurdle cleared by default

So we now know the Mologic biotech is officially recognised by the EU as of today, we ( Omega ) who are using the same passed Biotech are now just waiting on the ‘‘ease of self use trial via Belfast ‘ which was submitted in September

Suggest for shareholders we take a view now on when that will land ? On clearing we enjoy EU HUA

Frustrated as much as anyone but we are after Home Use authorisation, it appears to be it’s a high bar.

Been close to a month since anyone cleared by EU for HUA

We need to be on this next batch - fingers crossed

Not to take anything away from GDR - v pleased for the company and all their shareholders - but the one place we actually can sell our Antigen LFT is mainland Europe via CE professional use which is what GDR now enjoy.

HUA EU is the big one we want, plus CTDA of course.

Wonder if the BoD are thinking CTDA is close ? Or EU HUA?

In some ways it would be helpful to the share price if we don’t get the Q&A back just yet, let’s get an approval somewhere - makes sense in the circumstances

Kate,
Many of us feel the same on this point.

At the moment we are relying on our Chairman to be managing the situation, appreciate its not perfect but I think we have to give him the opportunity to sort out the compliance and we don’t distract the BoD to the main task at hand.

Bigbang, I agree with your assessment below.

It was either by default no one asked the question - not wanting to know - until the day before the RNS or incompetence to not have asked the question months ago considering the importance of the answer.

It’s by the by now as our share price reflects the situation, as you say once we gain approvals we should enjoy orders.

Just one mute point, IF the market would have known about the DHSC contract lapsing then it’s fair to say the share price would have fell months ago,by not asking the DHSC - for whatever reason - it created a false market in the shares and allowed insiders to dispose of their shares.

Touched base on this point yesterday, notice a few more picking up the fact Mologic biotech targets the N protein spike which for the first time a sovereign state ( France ) has come out and said they will only except antigen tests that target N Spike

We then have to look at who has the best performing LFT targeting the N protein? Mologic / Bill Gates have the highest performer reagent / buffer up to Ct27.

Going to be interesting to see how EU HUA goes the next week / 10 days it could well be the Mologic tech finally gets the recognition it deserves


https://twitter.com/martinestigter/status/1467495873273905156?s=10

Put aside it can be an LFT, what caught the eye was that France will only except antigen tests that target the N protein spike, this bodes well for Omega as the Mologic biotech targets the N Spike

If France has stipulated we can guess this will be the norm across the EU within days.

Let’s hope we clear EU HUA on the back of this news, we know Mologic are on the list for consideration and the EU update is possibly within the next week

https://www.schengenvisainfo.com/news/british-nationals-travelling-to-france-subject-to-additional-requirements-from-saturday/

Good post of Eazy

Says it all, no update since the 11th November
By default we are the list, so in the game.

We may get that bit of luck we need within the next 10 days

https://twitter.com/eazy_investor/status/1466677497609785346?s=10

Hi Marik
I enjoy your posts/ tweets re cellular biology / biotech
Notice you have a strong buy on ODX.

My view is the only difference between the Mologic & Avacta buffer / reagent is that Avacta enjoy Affimers which gives them an advantage which is noticeable > Ct 27

From Omega’s point of view I don’t think it’s a materiel difference, I also suspect Omega are using their own film and this may be improving their result very slightly - both tests are very close performance wise up to the level above.

So in effect both tests are very accurate up to > Ct27 , above this Avacta pulls away up to >Ct31 but it appears Omega’s performs up to the range that identifies asymptomatic carriers with higher viral loads, so there is no material difference between both tests that would affect Omega commercially ?

What’s your view on the Mologic biotech in regards to this latest variant?

Appreciate your opinion

Thanks

https://twitter.com/politicsforali/status/1466839569849069568?s=10

‘BREAKING: Covid will be a threat to the NHS for AT LEAST the next five years, and testing may be needed for over a decade - SAGE’

Ireland - additional restrictions

https://news.sky.com/story/covid-19-ireland-brings-in-new-restrictions-ahead-of-christmas-due-to-very-stark-health-advice-12485681

Come on Omega let’s get the test over the line

A paper just published - wee bit heavy - it does appear Covid 19 is going nowhere and testing will around for quite some time

‘A new study models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments. Since the study's completion, several of the predicted mutations have appeared in omicron, the most recently identified SARS-CoV-2 variant, offering insight into how omicron might be able to escape immune defense generated by mRNA vaccines and monoclonal antibody treatments for COVID-19

https://www.science.org/doi/abs/10.1126/science.abl6251

We touched base on this earlier - Testing before setting off
Norway / other Northern European countries moving this way

USA just announced similar and it appears there is a possibility LFT’s could well be excepted

When Omega clear CTDA it opens up another leg of travel to sell tests to U.K. passengers,

https://www.dailymail.co.uk/news/article-10271875/US-bound-travelers-scramble-COVID-tests-return-result-hours.html